XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Jun. 28, 2019
Jun. 29, 2018
Jun. 28, 2019
Jun. 29, 2018
Income Statement [Abstract]        
Revenue $ 4,010,761 $ 3,971,606 $ 12,276,097 $ 11,876,035
Costs and Expenses:        
Cost of services provided 3,594,978 3,526,293 11,029,382 10,611,532
Depreciation and amortization 148,779 156,934 447,408 443,646
Selling and general corporate expenses 78,185 101,715 270,600 282,327
Gain on sale of Healthcare Technologies     (156,309) 0
Costs and Expenses 3,821,942 3,784,942 11,591,081 11,337,505
Operating income 188,819 186,664 685,016 538,530
Interest and Other Financing Costs, net 82,220 89,776 249,375 256,562
Income Before Income Taxes 106,599 96,888 435,641 281,968
Provision for Income Taxes 23,535 24,172 72,589 (110,904)
Net income 83,064 72,716 363,052 392,872
Less: Net income attributable to noncontrolling interest 109 139 60 442
Net income attributable to Aramark stockholders $ 82,955 $ 72,577 $ 362,992 $ 392,430
Earnings per share attributable to Aramark stockholders:        
Basic (in dollars per share) $ 0.34 $ 0.29 $ 1.47 $ 1.60
Diluted (in dollars per share) $ 0.33 $ 0.29 $ 1.44 $ 1.56
Weighted Average Shares Outstanding:        
Basic (in shares) 246,928 246,028 246,665 245,588
Diluted (in shares) 251,147 251,857 251,271 252,231